CD24/Siglec-10 signaling disrupts tumor cell immune surveillance, and pathway blockade promotes macrophage phagocytosis of CD24-expressing tumor cells, effectively inhibiting tumor growth. The gene discussed is CD24; the disease is neoplasm.